IceCure Medical (NASDAQ:ICCM – Get Free Report) and Milestone Scientific (NYSE:MLSS – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.
Risk and Volatility
IceCure Medical has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.
Valuation & Earnings
This table compares IceCure Medical and Milestone Scientific”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IceCure Medical | $3.38 million | 3.52 | -$15.06 million | ($7.21) | -0.48 |
| Milestone Scientific | $8.90 million | 4.88 | -$6.93 million | ($0.05) | -9.82 |
Milestone Scientific has higher revenue and earnings than IceCure Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings for IceCure Medical and Milestone Scientific, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IceCure Medical | 1 | 1 | 3 | 0 | 2.40 |
| Milestone Scientific | 0 | 0 | 1 | 0 | 3.00 |
IceCure Medical currently has a consensus target price of $62.70, indicating a potential upside of 1,709.00%. Milestone Scientific has a consensus target price of $1.00, indicating a potential upside of 103.67%. Given IceCure Medical’s higher possible upside, research analysts clearly believe IceCure Medical is more favorable than Milestone Scientific.
Profitability
This table compares IceCure Medical and Milestone Scientific’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IceCure Medical | -441.60% | -211.73% | -119.13% |
| Milestone Scientific | -52.01% | -60.26% | -40.23% |
Insider & Institutional Ownership
0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Milestone Scientific beats IceCure Medical on 11 of the 14 factors compared between the two stocks.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
